GSK's Requip slow the loss of dopamine function in Parkinson's disease.
D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D018491:Dopamine Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D012720:Severity of Illness Index; D014055:Tomography, Emission-Computed; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole